Skip to content

HealthEquity

US · HQY #1726 by market cap Listed 1970
94.75 -2.63 -2.70%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 97.01 -0.38%
After-hours 94.75 0.00%
108.8483.4394.752026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on HQY?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -7.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 6.6% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 14:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall A
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 34.2x Better than 18%
Forward P/E 31.9x Better than 16%
Price / Sales 6.3x Better than 17%
P/E vs own 5-yr range 48th pctl Better than 62%
Growth A+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 15.1% Better than 76%
Net income CAGR (3Y) 84.8% Better than 94%
Free cash flow CAGR (3Y) 134.8% Better than 96%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 69.5% Better than 83%
Operating margin 24.9% Better than 84%
Net margin 16.4% Better than 74%
Return on equity 10.2% Better than 53%
Return on invested capital 7.9% Better than 60%
Momentum B

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -10.1% Better than 50%
6-month return 7.5% Better than 69%
12-month return (ex latest month) -0.9% Better than 32%
Distance below 52-week high 14.1% Better than 74%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.3x Better than 76%
Debt to assets 29.6% Better than 42%
Interest coverage 5.9x Better than 60%
Free cash flow / net income 189.7% Better than 75%
Analyst View B+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 27.8% Better than 45%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -8.42%
1M -1.92%
3M -9.13%
6M +8.22%
YTD +3.43%
1Y -5.94%
3Y +41.97%
5Y +54.47%

Key statistics

Price & volume

Prev close
97.38
Open
97.66
Day range
94.37 - 99.46
Avg price
96.00
Volume
741.34K
Turnover
71.17M
Amplitude
5.23%
52-week range
72.76 - 110.26

Valuation

P/E
38.52
P/E (TTM)
34.21
P/B
3.94
EPS
2.46
Net profit
203.48M
Net assets
1.99B

Share structure

Market cap
7.84B
Float cap
7.67B
Shares out
82.72M
Float shares
80.97M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 59% of range
72.76 110.26

14.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-5.22M net over the window

Short interest

Shares short
5.48M
As of
2026-10-30

Frequently asked questions

What is the current stock price of HealthEquity (HQY)?

HealthEquity last traded at 94.75. This page shows a periodic quote snapshot. Check the displayed quote time.

What is HealthEquity's market cap?

About 7.84B.

What is the P/E ratio of HealthEquity?

The trailing twelve-month P/E is 34.21, above its own 5-year average of 1.80 — in the middle of its historical range (48.33% percentile). See the Valuation tab for the full history.

Does HealthEquity pay a dividend?

HealthEquity does not currently pay a regular dividend.

Is HealthEquity a buy according to analysts?

The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 121.11, which implies 27.8% upside from the current price. This is not investment advice.

What is HealthEquity's StockVane Quant Rating?

The StockVane Momentum strategy currently rates HealthEquity a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

HealthEquity discussion 0 comments

Add a comment